NewsBenzingaRegenxbio: EPS del terzo trimestre pari a $(0,62), superiore alla stima di $(1,26); ricavi a $9,162 milioni, inferiori alla stima di $10,868 milioni Regenxbio: EPS del terzo trimestre pari a $(0,62), superiore alla stima di $(1,26); ricavi a $9,162 milioni, inferiori alla stima di $10,868 milioni Benzinga 2026.11.05 12:06 (GMT+0) Open on Benzinga Other news Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says How to Play NKE Stock as Nike Risks Becoming a Forever Turnaround Story